Clinical and molecular interrelations of dislipidemia and metabolic phenotype of osteoarthritis

Abstract

The work purpose: analysis of lipid parameters and inflammation markers in metabolic phenotype (MPh) osteoarthritis (OA) in correlation with the clinical manifestations of the disease. The study involved 90 patients with OA of the knee (average age of 64.66±8.43 year), of which 37 patients were with Diabetes mellitus type 2 (group MPh OA). 25 comparable volunteers were a control group. Lipid levels, interleukin-1β (IL-1β), tumor necrosis factor α (TNF-α), vasculo-endothelial growth factor A (VEGF-A), atherosclerotic changes of the common carotid artery by ultrasound were determined for all patients. It is shown that when MPh OA patients have a higher atherogenic index (as compared with the control group and patients with OA without the MPh), a greater thickness of the intima-media complex of the common carotid artery and the imbalance of cytokines in favor of increased pro-inflammatory molecules. In MPh OA group there was correlation of atherogenic lipids with proinflammatory cytokines (IL-1β, TNF-α), a marker of endothelial damage (VEGF-A) and clinical manifestations of OA. Thus, the results of the analysis confirm the important role of dyslipidemia and atherosclerosis in the pathogenesis of MPh OA, in particular indicate the possibility of integrating factors of cardiovascular comorbidity via molecular patterns IL-1β, TNF-α, VEGF-A.

Keywords

osteoarthritis / osteoarthritis / metabolic phenotype / inflammation / dyslipidemia / atherosclerosis

References

[1] 1.Laskarin G, Persic V, Kukic SR. Can pain intensity in osteoarthritis joint be indicator of the impairment of endothelial function? Med. Hypotheses. 2016; 94: 15-9.

[2] 1.Laskarin G., Persic V., Kukic S.R. Can pain intensity in osteoarthritis joint be indicator of the impairment of endothelial function? // Med. Hypotheses. 2016. Vol. 94. P. 15-19.

[3] 2.McAlindon TE, Bannuru RR, Sullivan MC. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014; 22 (3): 363-88.

[4] 2.McAlindon T.E., Bannuru R.R., Sullivan M.C. OARSI guidelines for the nonsurgical management of knee osteoarthritis // Osteoarthritis Cartilage. 2014. Vol. 22, №3. P. 363-388.

[5] 3.Strebkova EA, Solovyeva IV, Shara-pova EP. Ocenka vlijanija medikamentoznoj terapii ozhirenija na klinicheskie projavlenija osteoartroza kolennyh sustavov u zhenshhin s izbytochnoj massoj tela [Evalyetion of the impact of drug therapy for obesity on the clinical manifestation of knee osteoarthritis in over weight women]. Nauchno-prakticheskaja revmatologija [Rheumatology Science and Practice]. 2015; 53 (4): 391-6. (in Russian)

[6] 3.Стребкова Е.А., Соловьева И.В., Шарапова Е.П. Оценка влияния медикаментозной терапии ожирения на клинические проявления остеоартроза коленных суставов у женщин с избыточной массой тела // Научно-практическая ревматология. 2015. Т. 53, №4. С. 391-396.

[7] 4.Kabalyk MA. Kliniko-patogenetiches-koe znachenie arterial'noj gipertonii pri osteo-artrite [Clinical and pathogenetical value of arterial hypertension in osteoarthritis]. Uspehi sovremennoj nauki [Advances in modern science]. 2017; 2 (3): 112-6. (in Russian)

[8] 4.Кабалык М.А. Клинико-патогенетическое значение артериальной гипертонии при остеоартрите // Успехи современной науки. 2017. Т. 2, №3. С. 112-116.

[9] 5.Onuora S. Osteoarthritis: metabolic syndrome and risk of knee OA. Nat. Rev. Rheumatol. 2017; 13 (5): 257.

[10] 5.Onuora S. Osteoarthritis: metabolic syndrome and risk of knee OA // Nat. Rev. Rheumatol. 2017. Vol. 13, №5. P. 257.

[11] 6.Sekar S, Shafie SR, Prasadam I, Crawford R, Panchal SK, Brown L et al. Saturated fatty acids induce development of both metabolic syndrome and osteoarthritis in rats. Sci. Rep. 2017; 7: 46-57.

[12] 6.Sekar S., Shafie S.R., Prasadam I., Crawford R., Panchal S.K., Brown L. et al. Saturated fatty acids induce development of both metabolic syndrome and osteoarthritis in rats // Sci. Rep. 2017. №7. P. 46-57.

[13] 7.Duclos M. Osteoarthritis, obesity and type 2 diabetes: the weight of waist circumference. Ann. Phys. Rehabil. Med. 2016; 59 (3): 157-60.

[14] 7.Duclos M. Osteoarthritis, obesity and type 2 diabetes: the weight of waist circumference // Ann. Phys. Rehabil. Med. 2016. Vol. 59, №3. P. 157-160.

[15] 8.Ribeiro M, López de Figueroa P, Blanco FJ, Mendes AF, Caramés B. Insulin decreases autophagy and leads to cartilage degradation. Osteoarthritis Cartilage. 2016; 24 (4): 731-9.

[16] 8.Ribeiro M., López de Figueroa P., Blanco F.J., Mendes A.F., Caramés B. Insulin decreases autophagy and leads to cartilage degradation // Osteoarthritis Cartilage. 2016. Vol. 24, №4. P. 731-739.

[17] 9.Schett G, Kleyer A, Perricone C, Sahinbegovic E, Iagnocco A, Zwerina J et al. Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care. 2013; 36 (2): 403-9.

[18] 9.Schett G., Kleyer A., Perricone C., Sahinbegovic E., Iagnocco A., Zwerina J. et al. Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study // Diabetes Care. 2013. Vol. 36, №2. P. 403-409.

[19] 10.Tsezou A, Iliopoulos D, Malizos KN, Simopoulou T. Impaired expression of genes regulating cholesterol efflux in human osteoarthritic chondrocytes. J. Orthop. Res. 2010; 28 (8): 1033-9.

[20] 10.Tsezou A., Iliopoulos D., Malizos K.N., Simopoulou T. Impaired expression of genes regulating cholesterol efflux in human osteoarthritic chondrocytes // J. Orthop. Res. 2010. Vol. 28, №8. P. 1033-1039.

[21] 11.Hashimoto K, Mori S, Oda Y. Lectin-like oxidized low density lipoprotein receptor 1-deficient mice show resistance to instability-induced osteoarthritis. Scand. J. Rheumatol. 2016; 45 (5): 412-22.

[22] 11.Hashimoto K., Mori S., Oda Y. Lectin-like oxidized low density lipoprotein receptor 1-deficient mice show resistance to instability-induced osteoarthritis // Scand. J. Rheumatol. 2016. Vol. 45, №5. P. 412-422.

[23] 12.De Munter W, van der Kraan PM, van den Berg WB, van Lent PL. High systemic lev-els of low-density lipoprotein cholesterol: fuel to the flames in inflammatory osteoarthritis? Rheu-matology (Oxford). 2016; 55 (1): 16-24.

[24] 12.De Munter W., van der Kraan P.M., van den Berg W.B., van Lent P.L. High systemic levels of low-density lipoprotein cholesterol: fuel to the flames in inflammatory osteoarthritis? // Rheumatology (Oxford). 2016. Vol. 55, №1. P. 16-24.

[25] 13.Wang X, Hunter D, Xu J, Ding C. Metabolic triggered inflammation in osteoarthritis. Osteoarthritis Cartilage. 2015; 23 (1): 22-30.

[26] 13.Wang X., Hunter D., Xu J., Ding C. Metabolic triggered inflammation in osteoarthritis // Osteoarthritis Cartilage. 2015. Vol. 23, №1. P. 22-30.

[27] 14.Le Clanche S, Bonnefont-Rousselot D, Sari-Ali E, Rannou F, Borderie D. Inter-relations between osteoarthritis and metabolic syndrome: а common link? Biochimie. 2016; 121: 238-52.

[28] 14.Le Clanche S., Bonnefont-Rousselot D., Sari-Ali E., Rannou F., Borderie D. Inter-relations between osteoarthritis and metabolic syndrome: а common link? // Biochimie. 2016. Vol. 121. P. 238-252.

[29] 15.Rao Z, Wang S, Wang J. Peroxire-doxin 4 inhibits IL-1β-induced chondrocyte apoptosis via PI3K/AKT signaling. Biomed. Pharmacother. 2017; 90: 414-20.

[30] 15.Rao Z., Wang S., Wang J. Peroxiredoxin 4 inhibits IL-1β-induced chondrocyte apoptosis via PI3K/AKT signaling // Biomed. Pharmacother. 2017. Vol. 90. P. 414-420.

[31] 16.Jaiprakash A, Prasadam I, Feng JQ, Liu Y, Crawford R, Xiao Y. Phenotypic characterization of osteoarthritic osteocytes from the sclerotic zones: a possible pathological role in subchondral bone sclerosis. Int. J. Biol. Sci. 2012; 8 (3): 406-17.

[32] 16.Jaiprakash A., Prasadam I., Feng J.Q., Liu Y., Crawford R., Xiao Y. Phenotypic characterization of osteoarthritic osteocytes from the sclerotic zones: a possible pathological role in subchondral bone sclerosis // Int. J. Biol. Sci. 2012. Vol. 8, №3. P. 406-417.

[33] 17.Kabalyk MA. Rol' sosudistyh faktorov v patogeneze osteoartrita [The role of vascular factors in the pathogenesis of osteoarthritis]. Sovremennye problemy nauki i obrazovanija [Modern problems of science and education]. 2017; 2: 50-5. (in Russian)

[34] 17.Кабалык М.А. Роль сосудистых факторов в патогенезе остеоартрита // Современные проблемы науки и образования. 2017. №2. С. 50-55.

[35] 18.Chim SM, Tickner J, Chow ST, Kuek V, Guo B, Zhang G et al. Angiogenic factors in bone local environment. Cytokine Growth Factor Rev. 2013; 24 (3): 297-310.

[36] 18.Chim S.M., Tickner J., Chow S.T., Kuek V., Guo B., Zhang G. et al. Angiogenic factors in bone local environment // Cytokine Growth Factor Rev. 2013. Vol. 24, №3. P. 297-310.

[37] 19.Alvarez-Garcia O, Rogers NH, Smith RG, Lotz MK. Palmitate has proapoptotic and proinflammatory effects on articular cartilage and synergizes with interleukin-1. Arthritis Rheumatol. 2014; 66 (7): 1779-88.

[38] 19.Alvarez-Garcia O., Rogers N.H., Smith R.G., Lotz M.K. Palmitate has proapoptotic and proinflammatory effects on articular cartilage and synergizes with interleukin-1 // Arthritis Rheumatol. 2014. Vol. 66, №7. P. 1779-1788.

[39] 20.Kabalyk MA. Kliniko-patogeneti-cheskoe znachenie belkov teplovogo shoka s massoj 70 i 27 kDa pri osteoartrite [Clinical and pathogenetic significance of heat shock proteins with a mass of 70 and 27 kD in osteoarthritis]. Nauchno-prakticheskaja revmatologija [Scien-tific and Practical Rheumatology]. 2017; 2: 187-91. (in Russian)

[40] 20.Кабалык М.А. Клинико-патогенетическое значение белков теплового шока с массой 70 и 27 кДа при остеоартрите // Научно-практическая ревматология. 2017. №2. С. 187-191.

RIGHTS & PERMISSIONS

Kabalyk M.A., Sunyaykin A.B.